glp 1 agonists drug class GLP-1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? Upcoming wave of hormone-based therapies

13 The median expected protection we determined for GLP-1 receptor agonistswhich exceeds 18 yearsis the highest yet reported for drug-device combinations

Antibody generation has been more often seen with twice-daily exenatide and once-daily lixisenatide, presumably influencing their glycaemic effectiveness

found that GLP1RAs significantly raised LVEF and 6-minute walking test (6MWT) in T2DM with HF [48]

(Lausanne) 11 , 622589 (2020)

Never increase your dose without your healthcare providers guidance

If these findings translate clinically, targeting #TXNIP could represent a fundamentally new approach to weight maintenance after #weightloss therapy, an area where there are currently few options